1. 'Fhe role of risk factors in heart attacks occuLrring in men with pre-existing ischaemic heart diseasc;Phillips, A.N.; Shaper, A.G.; Pocock, S.J.; Walker, M.; MicFarlane, P.W.;Br Heart
2. Secondary prevention trials using clofibrate: a joint commentary on the Newcastle and Scottish trials;Dewar, H.A.; Ml, Oliver;BrMedJ,1971
3. Cooperative studies. Fifteen year mortality in coronary drug project patients; longterm benefit with niacin;Canner, P.L.; Berge, K.G.; Wenger, N.K.;J Am Coll Cardiol,1986
4. Reduction of mortality in the Stockholm ischaemic licart disease secondary study by combined treatment with clofibrate and nicotinic acid;Carlson, L.A.; Rosenhatner, G.;Acta Med Scand,1988
5. 'l'he relation of risk factors to the development of atherosclerosis in saphenousvein bypass grafts and the progression of disease in the natise circulation;Campeau, L.; Enjalbert, M.; Lesperance, J.; ct a;N EngIJ Med,1984